✦ LIBER ✦

PCN20 MAINTENANCE ERLOTINIB VERSUS PEMETREXED FOR THE TREATMENT OF NON-SMALL CELL LUNG CANCER: INDIRECT COMPARISON APPLYING REAL-LIFE OUTCOMES

✍ Scribed by R Casciano; H Bischoff; M Nuijten; E Malangone; J Ray

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN21 FIRST-LINE BEVACIZUMAB-BASED THERA

✍ K Berenson; C Chouaid; A Vergnenegre; S Sherman; S Walzer 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

PCN43 COST COMPARISON OF ERLOTINIB VERSU

✍ S Ravera; S Walzer; J Ray 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

PCN44 COST COMPARISON OF ERLOTINIB VERSU

✍ J Castro de Carpeño; AJ Castro-Gómez; S Walzer; J Ray 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

A cross-market cost comparison of erloti

✍ Nuijten, Mark J.C.; de Castro Carpeño, Javier; Chouaid, Christos; Vergnenègre, A 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 375 KB

Comparative effectiveness of bevacizumab

✍ Gee-Chen CHANG; Myung-Ju AHN; Elaine WRIGHT; Heung Tae KIM; Joo-Hang KIM; Jin Hy 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 178 KB

PCN17 Indirect Comparison of the Efficac

✍ C. Pereira; M. Sanches; J.F. Loff 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB